Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 2
1980 2
1982 2
1983 4
1984 2
1987 4
1989 1
1990 2
1991 2
1992 1
1993 2
1994 2
1995 1
1997 1
1999 2
2000 2
2001 1
2003 2
2004 3
2005 4
2006 1
2007 5
2008 3
2009 2
2010 3
2011 6
2012 7
2013 5
2014 4
2015 4
2016 4
2017 4
2018 4
2019 5
2020 6
2021 5
2022 4
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Underreporting of energy intake in weight loss maintainers.
Dahle JH, Ostendorf DM, Zaman A, Pan Z, Melanson EL, Catenacci VA. Dahle JH, et al. Am J Clin Nutr. 2021 Jul 1;114(1):257-266. doi: 10.1093/ajcn/nqab012. Am J Clin Nutr. 2021. PMID: 33742193 Free PMC article.
Kernel Flow: a high channel count scalable time-domain functional near-infrared spectroscopy system.
Ban HY, Barrett GM, Borisevich A, Chaturvedi A, Dahle JL, Dehghani H, Dubois J, Field RM, Gopalakrishnan V, Gundran A, Henninger M, Ho WC, Hughes HD, Jin R, Kates-Harbeck J, Landy T, Leggiero M, Lerner G, Aghajan ZM, Moon M, Olvera I, Park S, Patel MJ, Perdue KL, Siepser B, Sorgenfrei S, Sun N, Szczepanski V, Zhang M, Zhu Z. Ban HY, et al. Among authors: dahle jl. J Biomed Opt. 2022 Jan;27(7):074710. doi: 10.1117/1.JBO.27.7.074710. J Biomed Opt. 2022. PMID: 35043610 Free PMC article.
Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro.
Malenge MM, Maaland AF, Repetto-Llamazares A, Middleton B, Nijland M, Visser L, Patzke S, Heyerdahl H, Kolstad A, Stokke T, Ree AH, Dahle J. Malenge MM, et al. Among authors: dahle j. PLoS One. 2022 Apr 29;17(4):e0267543. doi: 10.1371/journal.pone.0267543. eCollection 2022. PLoS One. 2022. PMID: 35486574 Free PMC article.
Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma.
Kolstad A, Illidge T, Bolstad N, Spetalen S, Madsbu U, Stokke C, Blakkisrud J, Løndalen A, O'Rourke N, Beasley M, Jurczak W, Fagerli UM, Kaščák M, Bayne M, Obr A, Dahle J, Rojkjaer L, Pascal V, Holte H. Kolstad A, et al. Among authors: dahle j. Blood Adv. 2020 Sep 8;4(17):4091-4101. doi: 10.1182/bloodadvances.2020002583. Blood Adv. 2020. PMID: 32877524 Free PMC article. Clinical Trial.
107 results